Deucravacitinib Long-term Efficacy With Continuous Treatment in Plaque Psoriasis: 2-Year Results From the Phase 3 POETYK PSO-1 and PSO-2 Trials. (2023). SKIN The Journal of Cutaneous Medicine, 7(6), s243. https://doi.org/10.25251/skin.7.supp.243